Alopexx Enterprises works with scientists and entrepreneurs to build successful new companies. They invest in novel health care technologies at all stages of development and can serve as a lead investor or collaborate with a group of investors to advance important science. They also have the capabilities to provide management and development expertise where needed. To date, their initial investments have ranged from $1-20M.

Biotechnology

Alopexx Enterprises

Daniel R. Vlock

Peter Honig

Christine De Los Reyes

Thomas T. Thomas

The Scientific Advisory Team at Alopexx Enterprises evaluates the scientific and technological viability of potential investment opportunities, offers expertise on development strategies, and advises on the latest advancements in health care technologies. The team ensures that investments are based on sound scientific principles and have strong potential for successful commercialization.

Scientific Advisory Team

About

Team members

Other teams at Alopexx Enterprises

Board Members

Leadership Team